“Subcutaneous Treatment for Oncology: Reducing Administration Time and Adverse Effects”

by

2023-05-30 12:39:16

Oncology
–

Reduces administration time and adverse effects, compared to the intravenous route

The combined combination of subcutaneous pertuzumab and trastuzumab offers better quality of life, without affecting safety and oncological efficacy.

Offering quality of life to patients is another of the objectives of current research. Photo: DM.

1685455904
#subcutaneous #combination #monoclonal #antibodies #lengthens #broadens #quality #life #HER2 #breasts

Photo of author

Alexandra Hartman Editor-in-Chief

Editor-in-Chief Prize-winning journalist with over 20 years of international news experience. Alexandra leads the editorial team, ensuring every story meets the highest standards of accuracy and journalistic integrity.

“Inside the World of Script Kiddies: The Threat of Young Hackers Using Off-the-Shelf Scripts to Attack Computer Networks”

“Russian Pilot’s Incredible Landing on Aircraft Carrier: Real or Fake?”

Leave a Comment

This site uses Akismet to reduce spam. Learn how your comment data is processed.